Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: Pyrotinib and Trastuzumab
Sponsor: Youzhi Zhu